Techno Drugs (DHA:TECHNODRUG) Other Operating Expense: BDT621 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:TECHNODRUG Techno Drugs Ltd DHA:TECHNODRUG
37 GF Score
Price BDT42.70
! 5 Warning Signs
View Full Analysis

What is Techno Drugs Other Operating Expense?

Techno Drugs DHA:TECHNODRUG -1.39% 37 Other Operating Expense is BDT621 Mil as of Mar. 2026. GuruFocus rates DHA:TECHNODRUG with a GF Score™ of 37/100. The stock has 5 warning signs investors should review.

Techno Drugs's Other Operating Expense for the three months ended in Mar. 2026 was BDT3 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was BDT621 Mil.

Techno Drugs's quarterly Other Operating Expense declined from Sep. 2025 (BDT4 Mil) to Dec. 2025 (BDT4 Mil) and declined from Dec. 2025 (BDT4 Mil) to Mar. 2026 (BDT3 Mil).

Techno Drugs's annual Other Operating Expense increased from . 20 (BDT0 Mil) to Jun. 2024 (BDT690 Mil) but then declined from Jun. 2024 (BDT690 Mil) to Jun. 2025 (BDT622 Mil).

Techno Drugs Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Techno Drugs's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Techno Drugs Other Operating Expense Chart

Techno Drugs Annual Data
Trend Jun24 Jun25
Other Operating Expense
689.85 622.41

Techno Drugs Quarterly Data
Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 2.63 611.08 3.93 3.51 2.80
DHA:TECHNODRUG
37GF Score
Techno Drugs Ltd DHA:TECHNODRUG
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Techno Drugs Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT621 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of BDT621 Mil mean?
Techno Drugs (DHA:TECHNODRUG) has a Other Operating Expense of BDT621 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Techno Drugs and its competitors.
Is Techno Drugs' Other Operating Expense too high?
Techno Drugs' current Other Operating Expense is BDT621 Mil. Overall, Techno Drugs has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Techno Drugs' Other Operating Expense compare to ZTS and UTHR?
Techno Drugs' Other Operating Expense of BDT621 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Techno Drugs and its competitors. Techno Drugs's current Other Operating Expense is BDT621 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Drugs stock overvalued right now?
Techno Drugs (DHA:TECHNODRUG) has a current Other Operating Expense of BDT621 Mil. The current Other Operating Expense is BDT621 Mil. Techno Drugs' overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Techno Drugs (DHA:TECHNODRUG), the current Other Operating Expense is BDT621 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Techno Drugs Business Description

Address 31 Segun Bagicha, J K Tower, Dhaka, BGD, 1000
Techno Drugs Ltd is a pharmaceutical company. The company manufactures medicines for the healthcare market with quality products, a distribution channel, and doctor-patient acceptance. The company is also engaged in production of Anti-Cancer medicines and medicines for therapeutic areas like oncology, cardiovascular, diabetes, immune suppressor, anesthetics, life-saving antibiotics & contrast media in Bangladesh. The product portfolio of the company include Algicar Plus, Amoclav Forte, Adesol Oral Solution, Aminovet Injection, Apegestrol Tab, Docetex 20 Inj, and others.
37GF Score

Get the complete analysis for DHA:TECHNODRUG

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT42.70
Price